Skip to main content
NCBI home page
The Journal of Hygiene logoLink to The Journal of Hygiene
. 1980 Dec;85(3):313–326. doi: 10.1017/s0022172400063385

Epidemiology of mumps in the Netherlands.

J H Wagenvoort, M Harmsen, B J Boutahar-Trouw, C A Kraaijeveld, K C Winkler
PMCID: PMC2134016  PMID: 7462586

Abstract

In a Dutch population group neutralizing antibodies against mumps virus were determined by a plaque reduction technique, which proved reproducible, sensitive and specific. The results with sera of about 800 suburban children show that mumps is acquired at an early age with peak acquisition rates between the ages of four and six years. Over 90% have acquired mumps before the age of 14 years. More than 95% of about 1000 adults (18--65 years) have neutralizing antibodies. The relatively constant median titre suggests that antibodies persist during life. During a family study 77 clinical and 18 subclinical cases were observed. In families with index cases the attack rate was 26/37 = 0.71. Eleven children (excluding six babies) escaped infection. The mean attack rate during the epidemic was 0.30. The mean titre of mumps neutralizing antibody is maximal during the first year after the disease but declines during childhood. Mothers exposed to mumps in the family occasionally showed a significant rise in titre. Some seronegative mothers remained seronegative after exposure.

Full text

PDF
313

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black F. L., Houghton W. J. The significance of mumps hemagglutinin inhibition titers in normal populations. Am J Epidemiol. 1967 Jan;85(1):101–107. doi: 10.1093/oxfordjournals.aje.a120667. [DOI] [PubMed] [Google Scholar]
  2. Cooney M. K., Fox J. P., Hall C. E. The Seattle Virus Watch. VI. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae. Am J Epidemiol. 1975 Jun;101(6):532–551. doi: 10.1093/oxfordjournals.aje.a112125. [DOI] [PubMed] [Google Scholar]
  3. Ennis F. A., Douglas R. D., Stewart G. L., Hopps H. E., Meyer H. M., Jr A plaque neutralization test for determining mumps antibodies. Proc Soc Exp Biol Med. 1968 Dec;129(3):896–899. doi: 10.3181/00379727-129-33452. [DOI] [PubMed] [Google Scholar]
  4. Grillner L., Blomberg J. Hemolysis-in-gel and neutralization tests for determination of antibodies to mumps virus. J Clin Microbiol. 1976 Jul;4(1):11–15. doi: 10.1128/jcm.4.1.11-15.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. HSIUNG G. D., ISACSON P., TUCKER G. STUDIES OF PARAINFLUENZA VIRUSES. II. SEROLOGIC INTERRELATIONSHIPS IN HUMANS. Yale J Biol Med. 1963 Jun;35:534–544. [PMC free article] [PubMed] [Google Scholar]
  6. Hilleman M. R. Mumps vaccination. Mod Trends Med Virol. 1970;2(0):241–261. [PubMed] [Google Scholar]
  7. Kenny M. T., Jackson J. E., Medler E. M., Miller S. A., Osborn R. Age-related immunity to measles, mumps and rubella in Middle American and United States children. Am J Epidemiol. 1976 Feb;103(2):174–180. doi: 10.1093/oxfordjournals.aje.a112215. [DOI] [PubMed] [Google Scholar]
  8. Kenny M. T., Schell K. Microassay of measles and mumps virus and antibody in VERO cells. J Biol Stand. 1975;3(3):291–306. doi: 10.1016/0092-1157(75)90033-5. [DOI] [PubMed] [Google Scholar]
  9. LENNETTE E. H., JENSEN F. W., GUENTHER R. W., MAGOFFIN R. L. Serologic responses to para-influenza viruses in patients with mumps virus injection. J Lab Clin Med. 1963 May;61:780–788. [PubMed] [Google Scholar]
  10. LIAO S. J., BENENSON A. S. Immunity status of military recruits in 1951 in the United States. II. Results of mumps complement-fixation tests. Am J Hyg. 1954 May;59(3):273–281. doi: 10.1093/oxfordjournals.aje.a119640. [DOI] [PubMed] [Google Scholar]
  11. Mortimer P. P. Mumps prophylaxis in the light of a new test for antibody. Br Med J. 1978 Dec 2;2(6151):1523–1524. doi: 10.1136/bmj.2.6151.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Niederman J. C., Henderson J. R., Opton E. M., Black F. L., Skvrnova K. A nationwide serum survey of Brazilian military recruits, 1964. II. Antibody patterns with arboviruses, polioviruses, measles and mumps. Am J Epidemiol. 1967 Sep;86(2):319–329. doi: 10.1093/oxfordjournals.aje.a120742. [DOI] [PubMed] [Google Scholar]
  13. Sato H., Albrecht P., Hicks J. T., Meyer B. C., Ennis F. A. Sensitive neutralization test for virus antibody. 1. Mumps antibody. Arch Virol. 1978;58(4):301–311. doi: 10.1007/BF01317822. [DOI] [PubMed] [Google Scholar]
  14. Stelzner A., Talaska W. Epidemiologische und serologische Mumps-Analysen. Unter Berücksichtigung meningo-enzephalitischer Krankheitsbilder. Dtsch Gesundheitsw. 1972 Nov 2;27(44):2083–2089. [PubMed] [Google Scholar]
  15. Weibel R. E., Stokes J., Jr, Buynak E. B., Whitman J. E., Jr, Hilleman M. R. Live attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation. N Engl J Med. 1967 Feb 2;276(5):245–251. doi: 10.1056/NEJM196702022760501. [DOI] [PubMed] [Google Scholar]
  16. Yamane I., Matsuya Y., Jimbo K. An autoclavable powdered culture medium for mammalian cells. Proc Soc Exp Biol Med. 1968 Jan;127(1):335–336. doi: 10.3181/00379727-127-32685. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Hygiene are provided here courtesy of Cambridge University Press

RESOURCES